Angiodynamics (ANGO) Total Current Liabilities (2011 - 2026)

Angiodynamics has reported Total Current Liabilities for 16 years, with the latest figure at $66.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 15.27% year-over-year to $66.1 million; the trailing twelve-month figure through Feb 2026 stood at $66.1 million (down 15.27% YoY), and the FY2025 full-year result was $76.2 million, down 16.41% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $66.1 million, down from $72.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $91.2 million in Q2 2024, with the low at $49.4 million in Q1 2022.
• Historically, Total Current Liabilities has averaged $73.8 million across 5 years, with a median of $74.3 million in 2022.
• Annual changes were most pronounced in 2023 — Total Current Liabilities jumped 41.05% — and 2025, when it retreated 18.77%.
• Angiodynamics' Total Current Liabilities stood at $73.6 million in 2022, then advanced by 6.08% to $78.0 million in 2023, then climbed by 13.53% to $88.6 million in 2024, then retreated by 18.77% to $72.0 million in 2025, then decreased by 8.19% to $66.1 million in 2026.
• The last three Total Current Liabilities figures came in at $66.1 million (Q1 2026), $72.0 million (Q4 2025), and $68.3 million (Q3 2025), per Business Quant data.